Covenant Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.23M | Sell |
12,700
-772
| -6% | -$180K | 0.54% | 48 |
|
|
2026
Q1 | $3.29M | Sell |
13,472
-90
| -0.7% | -$21K | 0.5% | 59 |
|
|
2025
Q4 | $2.81M | Sell |
13,562
-214
| -2% | -$42.3K | 0.33% | 61 |
|
|
2025
Q3 | $2.55M | Sell |
13,776
-221
| -2% | -$37.9K | 0.29% | 62 |
|
|
2025
Q2 | $2.14M | Sell |
13,997
-275
| -2% | -$42.3K | 0.32% | 63 |
|
|
2025
Q1 | $2.37M | Sell |
14,272
-1,204
| -8% | -$188K | 0.52% | 55 |
|
|
2024
Q4 | $2.24M | Sell |
15,476
-1,225
| -7% | -$190K | 0.34% | 69 |
|
|
2024
Q3 | $2.71M | Sell |
16,701
-875
| -5% | -$139K | 0.43% | 59 |
|
|
2024
Q2 | $2.57M | Sell |
17,576
-1,834
| -9% | -$273K | 0.41% | 59 |
|
|
2024
Q1 | $3.07M | Sell |
19,410
-391
| -2% | -$62.2K | 0.5% | 50 |
|
|
2023
Q4 | $3.1M | Sell |
19,801
-2,499
| -11% | -$383K | 0.56% | 49 |
|
|
2023
Q3 | $3.47M | Sell |
22,300
-1,563
| -7% | -$258K | 0.92% | 34 |
|
|
2023
Q2 | $3.95M | Sell |
23,863
-27
| -0.1% | -$4.36K | 1% | 32 |
|
|
2023
Q1 | $3.7M | Sell |
23,890
-2,183
| -8% | -$352K | 0.88% | 36 |
|
|
2022
Q4 | $4.61M | Buy |
26,073
+6,841
| +36% | +$1.18M | 1.1% | 27 |
|
|
2022
Q3 | $3.14M | Buy |
19,232
+288
| +2% | +$48.7K | 0.9% | 33 |
|
|
2022
Q2 | $3.36M | Buy |
18,944
+15
| +0.1% | +$2.67K | 1.07% | 28 |
|
|
2022
Q1 | $3.35M | Buy |
18,929
+15
| +0.1% | +$2.55K | 0.91% | 36 |
|
|
2021
Q4 | $3.24M | Sell |
18,914
-67
| -0.4% | -$11K | 0.86% | 36 |
|
|
2021
Q3 | $3.06M | Sell |
18,981
-783
| -4% | -$134K | 0.91% | 36 |
|
|
2021
Q2 | $3.26M | Sell |
19,764
-61
| -0.3% | -$10.1K | 0.97% | 34 |
|
|
2021
Q1 | $3.26M | Buy |
19,825
+20
| +0.1% | +$3.24K | 1.02% | 34 |
|
|
2020
Q4 | $3.12M | Sell |
19,805
-1,502
| -7% | -$222K | 1.03% | 33 |
|
|
2020
Q3 | $3.17M | Sell |
21,307
-175
| -0.8% | -$25.9K | 1.02% | 21 |
|
|
2020
Q2 | $3.02M | Buy |
21,482
+547
| +3% | +$79.7K | 0.67% | 31 |
|
|
2020
Q1 | $2.75M | Buy |
20,935
+3,582
| +21% | +$508K | 0.83% | 23 |
|
|
2019
Q4 | $2.53M | Buy |
17,353
+51
| +0.3% | +$6.92K | 1.11% | 27 |
|
|
2019
Q3 | $2.24M | Sell |
17,302
-115
| -0.7% | -$15.2K | 1.12% | 30 |
|
|
2019
Q2 | $2.43M | Sell |
17,417
-924
| -5% | -$128K | 1.26% | 20 |
|
|
2019
Q1 | $2.56M | Sell |
18,341
-1,000
| -5% | -$134K | 1.35% | 19 |
|
|
2018
Q4 | $2.67M | Hold |
19,341
| – | – | 1.35% | 19 |
|
|
2018
Q3 | $2.67M | Sell |
19,341
-250
| -1% | -$33.2K | 1.35% | 19 |
|
|
2018
Q2 | $2.38M | Buy |
19,591
+800
| +4% | +$99.8K | 1.28% | 17 |
|
|
2018
Q1 | $2.41M | Sell |
18,791
-43
| -0.2% | -$5.81K | 1.39% | 17 |
|
|
2017
Q4 | $2.63M | Buy |
18,834
+43
| +0.2% | +$5.99K | 1.53% | 11 |
|
|
2017
Q3 | $2.44M | Hold |
18,791
| – | – | 1.49% | 14 |
|
|
2017
Q2 | $2.49M | Hold |
18,791
| – | – | 1.59% | 11 |
|
|
2017
Q1 | $2.34M | Sell |
18,791
-1,875
| -9% | -$224K | 1.58% | 11 |
|
|
2016
Q4 | $2.38M | Buy |
+20,666
| New | +$2.39M | 1.6% | 15 |
|
Other funds holding JNJ
Covenant Asset Management's JNJ Position: Q2 2026 in Review
Covenant Asset Management reduced its Johnson & Johnson (JNJ) stake by 5.7% in Q2 2026, selling an estimated $180K and leaving 12,700 shares worth $3.23M. The position accounts for 0.54% of the portfolio, ranked #48.
Covenant Asset Management first reported a position in JNJ in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.61M in Q4 2022. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Covenant Asset Management held 12,700 shares of Johnson & Johnson worth $3.23M as of Q2 2026.
- Covenant Asset Management sold 772 Johnson & Johnson shares in Q2 2026, an estimated $180K.
- Johnson & Johnson made up 0.54% of Covenant Asset Management's portfolio in Q2 2026, its #48 holding.
- Covenant Asset Management first reported a position in Johnson & Johnson in Q4 2016 and has held it in 39 quarters since.
- Covenant Asset Management's Johnson & Johnson position peaked at $4.61M in Q4 2022.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Covenant Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.